- call +1-201-465-4211
- email sales@mrinsights.biz
Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and protein-based drugs.
Scope of the Report:
This report focuses on the Oral Proteins and Peptides in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The oral protein and peptide-based therapeutics market for diabetes is expected to grow considerably in the near future, owing to factors such as increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle.
The U.S. is anticipated to generate the highest revenue in the oral proteins and peptides market in 2023. The rest of the world possesses high market potential for the growth of the market, owing to increase in awareness about oral peptide and protein therapeutics based treatment and rise in oral peptide and protein therapeutics applications. This region is anticipated to experience fast-paced growth, in terms of development and use of protein therapeutics.
The diabetes application is anticipated to occupy the largest share in the oral proteins and peptides market in 2023 owing to the high adoption of oral insulin, surge in geriatric population, and rise in prevalence of diabetes.
The worldwide market for Oral Proteins and Peptides is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Allergan
AstraZeneca
Biocon
Generex Biotechnology
Novo Nordisk
Synergy Pharmaceuticals
Tarsa Therapeutics
Sanofi
Hoffmann-La Roche
Synthetic Biologics
Hovione
Novartis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Linaclotide
Plecanatide
Calcitonin
Insulin
Octreotide
Market Segment by Applications, can be divided into
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
There are 15 Chapters to deeply display the global Oral Proteins and Peptides market.
Chapter 1, to describe Oral Proteins and Peptides Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Oral Proteins and Peptides, with sales, revenue, and price of Oral Proteins and Peptides, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Oral Proteins and Peptides, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Oral Proteins and Peptides market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Oral Proteins and Peptides sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Oral Proteins and Peptides Introduction
1.2 Market Analysis by Type
1.2.1 Linaclotide
1.2.2 Plecanatide
1.2.3 Calcitonin
1.2.4 Insulin
1.2.5 Octreotide
1.3 Market Analysis by Applications
1.3.1 Gastric & Digestive Disorders
1.3.2 Bone Diseases
1.3.3 Diabetes
1.3.4 Hormonal Disorders
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Oral Proteins and Peptides Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 Oral Proteins and Peptides Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Biocon
2.3.1 Business Overview
2.3.2 Oral Proteins and Peptides Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Biocon Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Generex Biotechnology
2.4.1 Business Overview
2.4.2 Oral Proteins and Peptides Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Generex Biotechnology Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novo Nordisk
2.5.1 Business Overview
2.5.2 Oral Proteins and Peptides Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novo Nordisk Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Synergy Pharmaceuticals
2.6.1 Business Overview
2.6.2 Oral Proteins and Peptides Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Synergy Pharmaceuticals Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Tarsa Therapeutics
2.7.1 Business Overview
2.7.2 Oral Proteins and Peptides Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Tarsa Therapeutics Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Oral Proteins and Peptides Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Hoffmann-La Roche
2.9.1 Business Overview
2.9.2 Oral Proteins and Peptides Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Hoffmann-La Roche Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Synthetic Biologics
2.10.1 Business Overview
2.10.2 Oral Proteins and Peptides Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Synthetic Biologics Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Hovione
2.11.1 Business Overview
2.11.2 Oral Proteins and Peptides Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Hovione Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Novartis
2.12.1 Business Overview
2.12.2 Oral Proteins and Peptides Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Novartis Oral Proteins and Peptides Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oral Proteins and Peptides Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Oral Proteins and Peptides Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Oral Proteins and Peptides Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Oral Proteins and Peptides Manufacturer Market Share in 2017
3.3.2 Top 6 Oral Proteins and Peptides Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Oral Proteins and Peptides Market Analysis by Regions
4.1 Global Oral Proteins and Peptides Sales, Revenue and Market Share by Regions
4.1.1 Global Oral Proteins and Peptides Sales and Market Share by Regions (2013-2018)
4.1.2 Global Oral Proteins and Peptides Revenue and Market Share by Regions (2013-2018)
4.2 North America Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
4.3 Europe Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
4.5 South America Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
5 North America Oral Proteins and Peptides by Countries
5.1 North America Oral Proteins and Peptides Sales, Revenue and Market Share by Countries
5.1.1 North America Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)
5.1.2 North America Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)
5.2 United States Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
5.3 Canada Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
5.4 Mexico Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
6 Europe Oral Proteins and Peptides by Countries
6.1 Europe Oral Proteins and Peptides Sales, Revenue and Market Share by Countries
6.1.1 Europe Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)
6.2 Germany Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
6.3 UK Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
6.4 France Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
6.5 Russia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
6.6 Italy Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
7 Asia-Pacific Oral Proteins and Peptides by Countries
7.1 Asia-Pacific Oral Proteins and Peptides Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)
7.2 China Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
7.3 Japan Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
7.4 Korea Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
7.5 India Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
8 South America Oral Proteins and Peptides by Countries
8.1 South America Oral Proteins and Peptides Sales, Revenue and Market Share by Countries
8.1.1 South America Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)
8.1.2 South America Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
8.3 Argentina Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
8.4 Colombia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
9 Middle East and Africa Oral Proteins and Peptides by Countries
9.1 Middle East and Africa Oral Proteins and Peptides Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Oral Proteins and Peptides Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Oral Proteins and Peptides Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
9.3 UAE Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
9.4 Egypt Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
9.5 Nigeria Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
9.6 South Africa Oral Proteins and Peptides Sales and Growth Rate (2013-2018)
10 Global Oral Proteins and Peptides Market Segment by Type
10.1 Global Oral Proteins and Peptides Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Oral Proteins and Peptides Sales and Market Share by Type (2013-2018)
10.1.2 Global Oral Proteins and Peptides Revenue and Market Share by Type (2013-2018)
10.2 Linaclotide Sales Growth and Price
10.2.1 Global Linaclotide Sales Growth (2013-2018)
10.2.2 Global Linaclotide Price (2013-2018)
10.3 Plecanatide Sales Growth and Price
10.3.1 Global Plecanatide Sales Growth (2013-2018)
10.3.2 Global Plecanatide Price (2013-2018)
10.4 Calcitonin Sales Growth and Price
10.4.1 Global Calcitonin Sales Growth (2013-2018)
10.4.2 Global Calcitonin Price (2013-2018)
10.5 Insulin Sales Growth and Price
10.5.1 Global Insulin Sales Growth (2013-2018)
10.5.2 Global Insulin Price (2013-2018)
10.6 Octreotide Sales Growth and Price
10.6.1 Global Octreotide Sales Growth (2013-2018)
10.6.2 Global Octreotide Price (2013-2018)
11 Global Oral Proteins and Peptides Market Segment by Application
11.1 Global Oral Proteins and Peptides Sales Market Share by Application (2013-2018)
11.2 Gastric & Digestive Disorders Sales Growth (2013-2018)
11.3 Bone Diseases Sales Growth (2013-2018)
11.4 Diabetes Sales Growth (2013-2018)
11.5 Hormonal Disorders Sales Growth (2013-2018)
12 Oral Proteins and Peptides Market Forecast (2018-2023)
12.1 Global Oral Proteins and Peptides Sales, Revenue and Growth Rate (2018-2023)
12.2 Oral Proteins and Peptides Market Forecast by Regions (2018-2023)
12.2.1 North America Oral Proteins and Peptides Market Forecast (2018-2023)
12.2.2 Europe Oral Proteins and Peptides Market Forecast (2018-2023)
12.2.3 Asia-Pacific Oral Proteins and Peptides Market Forecast (2018-2023)
12.2.4 South America Oral Proteins and Peptides Market Forecast (2018-2023)
12.2.5 Middle East and Africa Oral Proteins and Peptides Market Forecast (2018-2023)
12.3 Oral Proteins and Peptides Market Forecast by Type (2018-2023)
12.3.1 Global Oral Proteins and Peptides Sales Forecast by Type (2018-2023)
12.3.2 Global Oral Proteins and Peptides Market Share Forecast by Type (2018-2023)
12.4 Oral Proteins and Peptides Market Forecast by Application (2018-2023)
12.4.1 Global Oral Proteins and Peptides Sales Forecast by Application (2018-2023)
12.4.2 Global Oral Proteins and Peptides Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Oral Proteins and Peptides Picture
Table Product Specifications of Oral Proteins and Peptides
Figure Global Sales Market Share of Oral Proteins and Peptides by Types
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
